ANTI-CEACAM5 ANTIBODY-DRUG CONJUGATES
AR135339A1Pending Publication Date: 2026-08-19BRISTOL MYERS SQUIBB CO
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- ARP20250100527
- Authority / Receiving Office
- AR · AR
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-08-02
- Filing Date
- 2025-02-26
- Publication Date
- 2026-08-19
Need to check novelty before this filing date? Find Prior Art
No text content released.
Claims
An antibody-drug conjugate (ADC) having formula (1). A pharmaceutical composition comprising the ADC of any of the preceding claims, and a pharmaceutically acceptable carrier. A method of producing the ADC of any of the preceding claims comprising conjugating the anti-CEACAM5 antibody or the antigen-binding portion thereof with hexathecan.